reference/325265

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/325265

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1931
issn	0009-7322 1524-4539
issueIdentifier	15
pageRange	1924-1931
publicationName	Circulation
startingPage	1924
bibliographicCitation	de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlöf B, de Faire U, Fyhrquist F, Ibsen H, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Devereux RB. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study. Circulation. 2005 Apr 19;111(15):1924–31. doi: 10.1161/01.cir.0000161799.91577.0a. PMID: 15837945.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9248e7d38b3b2078a6d8d7d374344fc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_364894b88f1aae9b6847d8b81499dcfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f2398e146d6307a8edd6387bb47cf08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_071b6ee5d4f87818ea0c018bfb88dd68 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6753dbdd59236ed07f4e53cf2156270 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db834f06a06565325d7caa698c596f78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b54330ea2497d9375e5aa3b5eeca6644 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa9c2f94802401a2781faafdbed4601 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_222077d8ee61f5b62221f6c11f7c28d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b965639c24e01c0ac75fc97771731ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a706cd3f0f8541f7cbc1f021e36a4a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f077cf050cb5a42ad2debc1af37e0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ac787fa7ab28f01c2d6b9d639a152f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4de71ef25d545575fe914a5a9cadb45c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3732-524X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f658fe92148f1fba2768147da42e786 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_301de199edce2756c2e7104e18ceafe6
date	2005-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15837945 https://doi.org/10.1161/01.cir.0000161799.91577.0a
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2979 https://portal.issn.org/resource/ISSN/1524-4539 https://portal.issn.org/resource/ISSN/0009-7322
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study
discusses	http://id.nlm.nih.gov/mesh/M0001900 http://id.nlm.nih.gov/mesh/M0029400
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006973Q000503 http://id.nlm.nih.gov/mesh/D002318Q000503 http://id.nlm.nih.gov/mesh/D017379Q000503 http://id.nlm.nih.gov/mesh/D013008Q000502
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001262Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001835 http://id.nlm.nih.gov/mesh/D019808Q000627 http://id.nlm.nih.gov/mesh/D002318Q000188 http://id.nlm.nih.gov/mesh/D002318Q000209 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015992 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D017379Q000188 http://id.nlm.nih.gov/mesh/D009765 http://id.nlm.nih.gov/mesh/D016016
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10017 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263

Total number of triples: 71.